Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma

CD133 is currently believed to be one of the best colorectal cancer stem cell markers. This study aimed to evaluate prognostic significance of CD133 expression in colorectal cancer patients. A total of 303 patients with stage I to III colorectal cancer who underwent curative surgical resection from...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Youn Young, An, Chang Hyeok, Oh, Seong Taek, Chang, Eun Deock, Lee, Jaeim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708874/
https://www.ncbi.nlm.nih.gov/pubmed/31393377
http://dx.doi.org/10.1097/MD.0000000000016709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708874/
https://www.ncbi.nlm.nih.gov/pubmed/31393377
http://dx.doi.org/10.1097/MD.0000000000016709

Ejemplares similares